X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Genes & Diseases

期刊標題檢索 GENES DIS/Genes 最新評論: Did you accept the short communication? (2026-07-27)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Genes & Diseases]您好,您是該頁面的第 51964 位訪客。

期刊簡介
期刊名稱Genes & Diseases Genes & Diseases
LetPub Score
7.0
50 ratings
Rate

Reputation
8.8

Influence
5.7

Speed
7.0

期刊簡稱GENES DIS/Genes and Diseases
ISSN2352-4820
E-ISSN2352-3042
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
10.401.7761.442
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Genetics (clinical)
Q17 / 100
Category: Medicine
Subcategory: Biochemistry
Q156 / 448
Category: Medicine
Subcategory: Molecular Biology
Q162 / 414
Category: Medicine
Subcategory: Cell Biology
Q153 / 289

自引率 (2023-2024)2.90%自引率趨勢
掲載範囲
Genes & Diseases is an international journal for molecular and translational medicine. The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases. Publication formats include full length research article, review article, short communication, correspondence, perspectives, commentary, views on news, and research watch.

Aims and Scopes

Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis will be placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
官方網站https://www.journals.elsevier.com/genes-and-diseases
在線稿件提交https://www.editorialmanager.com/GENDIS
開放訪問Yes
出版商ELSEVIER
主題領域Multiple
出版國/地區PEOPLES R CHINA
發行頻率四半期刊行
創刊年2014
每年文章數209每年文章數趨勢
黃金OA百分比98.09%
OA Related Info
APC: Yes( USD2500; )
APC waiver:No
Other charges: No
Keywords: molecular genetics、cell biology、stem cell biology、gene regulation and epigenetics、immunity and infection、neuroscience
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ115/328
GENETICS & HEREDITYSCIEQ14/192
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2352-4820%5BISSN%5D
平均審稿時間 *來自出版商的數據: Time to First Decision: 2.3 weeks; Review Time: 3.7 weeks; Publication Time: 1.6 weeks;
來自作者的數據: 50 Weeks
競爭力 *來自作者的數據: 14%
來自Elsevier的數據: 14%
參考鏈接
相關期刊 【Genes & Diseases】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 649.80
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 159.20
    LANCETH-index: 700

    CiteScore: 92.40
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 74.80
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 126.60
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 71.30
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 96.20
    MMWR Recommendations and ReportsH-index: 0

    CiteScore: 131.20
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 83.50
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 26.00
    學科內最受檢索的期刊 頁面查看次數
    PHARMACEUTICAL BIOLOGY23315201
    Frontiers in Pharmacology6580504
    Oncology Letters1620876
    BIOMATERIALS1580805
    Cancer Medicine1079345
    Oncogenesis1009473
    JOURNAL OF ETHNOPHARMACOLOGY730194
    Archives of Medical Science720496
    MEDICINE710450
    Frontiers in Oncology601386
  •  

    Genes & Diseases Genes & Diseases
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Genes & Diseases] 的評論撰寫評論
作者: 秋天的鱼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-07-27 16:06:56 評論於
Did you accept the short communication?
(0) 讚! | 秋天的鱼

作者: adeadpoet


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-06-26 09:20:23 評論於
I'm sorry, but I cannot provide a translation without the original text. Please provide the text you would like translated into English.
(0) 讚! | adeadpoet

作者: Zhenting He


領域: 医学
審稿時間: 6.0 month(s)
結果: 修改後接受


撰寫評論

2026-06-23 19:26:05 評論於
The submission was made in May 2025, and it took 6 months for review and revisions before it was finally accepted. The feedback provided was very constructive, the review process was professional, and the editors were friendly. I hope the journal will continue to improve and thrive!
(0) 讚! | Zhenting He

作者: adeadpoet


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-06-08 14:57:36 評論於
Please translate the following paragraph into English: X
(0) 讚! | adeadpoet

作者: adeadpoet


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-05-11 14:56:19 評論於
Submit the first draft on May 6, 2026.
Request for format revision on May 11, 2026, and resubmit on the same day.
(0) 讚! | adeadpoet

作者: 天上得云在飘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-02-22 20:06:18 評論於
What was the result later on?
(0) 讚! | 天上得云在飘

作者: 天上得云在飘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-02-22 20:04:21 評論於
What were the results in the end?
(0) 讚! | 天上得云在飘

作者: wqw430


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-11-07 11:41:10 評論於
On August 10th, I submitted the application, and on September 2nd, it showed "under review". On November 6th, I followed up and was told that they are still missing one reviewer.
(0) 讚! | wqw430

作者: liya


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-04-28 17:17:39 評論於
Submitted on January 22nd, 25 years, it was with the editor until March 22nd, and it was under review on April 28th after a reminder in between. I hope I won't encounter a 6-month peer review process.
(0) 讚! | liya

作者: LeslieRed


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-01-29 02:06:08 評論於
We became "Under Review" around 1.17, and by 1.25 it changed to "decision in progress." Does this mean it has been rejected directly?
(0) 讚! | LeslieRed

作者: 雨润平江


領域: 医学
審稿時間: 6.0 month(s)
結果: 拒稿


撰寫評論

2024-11-20 17:49:51 評論於
May 6 2024 Submit
Jun 2 2024 With Editor
Jun 16 2024 Under Review
Sep 26 2024 Decision in Process
Nov 17 2024 Requested to resubmit as a short communication.
It's frustrating to have to wait so long, but what's even more irritating is the statement: "We completed the peer review process of your manuscript." Six months, who has ever heard of a six-month peer review process?
(0) 讚! | 雨润平江

作者: Dr. Wang


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2023-08-30 19:44:04 評論於
Hope gets better and better
(1) 讚! | Dr. Wang

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Genes & Diseases] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*